Synthesis and preliminary biological studies of the novel conjugate 188Re-labeled meso-tetrakis(4-sulfophenyl)porphyrin in mice

Nuclear Medicine and Biology

Volumn 34, Issue 6, 2007, Pages 643-649

  Jia, Zhiyun ^a   Deng, Houfu ^a   Pu, Manfei ^b  

^a SICHUAN UNIVERSITY   (China)

^b RESEARCH CENTER OF LASER FUSION   (China)

Author keywords

Biodistribution; Mice; Porphyrin derivative; Radionuclide therapy; Rhenium 188; Tumor bearing nude mice

Indexed keywords

ASCORBIC ACID; PORPHYRIN DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TETRAKIS(4 SULFOPHENYL)PORPHINE RE 188; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL DESTRUCTION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG LABELING; DRUG STABILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MELANOMA; MOUSE; NONHUMAN; NUDE MOUSE;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; ISOTOPE LABELING; LIVER NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; METALLOPORPHYRINS; MICE; MICE, INBRED BALB C; MICE, NUDE; RADIOISOTOPES; RADIOPHARMACEUTICALS; RHENIUM; TISSUE DISTRIBUTION;

EID: 34547830392     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.05.006     Document Type: Article

References (31)

1. Policard A. Etudes sur les aspects offerts par des tumeurs experimentales examinees a la lumiere de woods. C R Soc Biol 91 (1924) 14-32
2. Figge F.H.J., Weiland G.S., and Manganiello L.O.J. Cancer detection and therapy: affinity of neoplastic, embryonic and traumatized tissues for porphyrin and metalloporphyrin. Proc Soc Exp Biol Med 68 (1948) 640-641
3. Manganiello L.O.J., and Figge F.H.J. Cancer detection and therapy: II. Methods of preparation and biological effects of metalloporphyrin. Bull School Med Univ Maryland 36 (1951) 3-7
4. Peck G.C., Mack H.P., and Figge F.H.J. Cancer detection and therapy: III. Affinity of lymphatic tissues for hematoporphyrin. Bull School Med Univ Maryland 38 (1953) 124-127
5. Winkelman J. Intracellular localization of hematoporphyrin in a transplanted tumour. J Natl Cancer Inst 27 (1961) 1369-1377
6. Lipson R.L., Baldes E.J., and Gray M.S. Hematoporphyrin derivative for detection and management of cancer. Cancer 20 (1967) 2255-2257
7. Fawwaz R.A., Wang T.S.T., and Alderson P.O. Evaluation of radioporphyrins as tumour seeking agents in experimental animals. J Nucl Med 22 (1981) P50
8. Jori G. Tumour photosensitizers: approaches to enhance selectivity and efficiency of photodynamic therapy. J Photochem Photobiol B 36 (1996) 87-93
9. Winkelman J. The distribution of tetraphenyl-porphinesulphonate in the tumor-bearing rat. Cancer Res 22 (1962) 589-596
10. 14C-labelled tetraphenylporphinesulfonate. Cancer Res 27 (1967) 2060-2064
11. 57 tetraphenylporphine-sulfonate in cancer patients. J Nucl Med 5 (1964) 462-470
12. Hambright P., Fawwaz R.A., Valk P., et al. The distribution of various water-soluble radioactive metalloporphyrins in tumour bearing mice. Bioinorg Chem 5 (1975) 87-92
13. Hambright P., Smart J.C., McRea J., et al. Tumor imaging with 57-cobalt (III) sandwich complexes and 57-cobalt (III) porphyrins. Inorg Nucl Chem Lett 17 (1976) 217-222
14. Zanelli G.D., and Kaelin A.D. Synthetic porphyrins as tumour localizing agents. Br J Radiol 54 (1981) 403-407
15. 99mTc labelled porphyrin for specific imaging of sarcoma 120: synthesis and biological study in a Swiss mouse model. J Label Comp Radiopharm 38 (1996) 411-418
16. 3,4BCPP) for tumor imaging. J Porphyrins Phthalocyanines 5 (2001) 824-828
17. Chatterjee S.R., Murugesan S., Kamat J.P., et al. Photodynamic effects induced by meso-tetrakis[4-(carboxymethyleneoxy)phenyl] porphyrin using rat hepatic microsomes as model membranes. Arch Biochem Biophys 339 (1997) 242-249
18. 3,4BCPC for detection and treatment of tumors. J Photochem Photobiol B 68 (2002) 33-38
19. 3 chelate: conjugation optimization, in vitro stability and animal studies. J Radioanal Nucl Chem 261 (2004) 337-342
20. 188Re generator. Appl Radiat Isot 45 (1994) 1123-1128
21. Pillai M.R.A., Samuel G., Banerjee S., et al. Technetium-99m complexes of polydentate amine-pyrrole and amine-thiophene ligands. Nucl Med Biol 26 (1999) 69-77
22. Ning Y.-C. Mass spectrogram analysis: the mass chromatogram of benzene compound. In: Ning Y.-C. (Ed). Structural identification of organic compounds and organic spectroscopy. 2nd ed. (2000), Science Press, Beijing 301-303
23. 186Re-bleomycin. Nucl Sci Tech 9 1 (1998) 26-28
24. 188Re-labeled radiopharmaceuticals: an overview of promising results from initial clinical trials. Cancer Biother Radiopharm 18 (2003) 707-717
25. Nakajima S., Takemura T., Sakata I., et al. Tumor-localizing activity of porphyrin and its affinity to LDL transferring. Cancer Lett 92 1 (1995) 113-118
26. Shibata Y., Matsumura A., Yoshida F., et al. Competitive uptake of porphyrin and LDL via the LDL receptor in glioma cell lines: flow cytometric analysis. Cancer Lett 166 1 (2001) 79-87
27. Nakajima S., Moriyama T., Hayashi H., et al. Hemopexin as a carrier protein of tumor-localizing Ga-metalloporphyrin-ATN-2. Cancer Lett 149 1-2 (2000) 221-226
28. Shibata Y., Matsumura A., Yoshida F., et al. Cell cycle dependency of porphyrin uptake in a glioma cell line. Cancer Lett 129 1 (1998) 77-85
29. Alexandrine M., Sonia F., Corine V., et al. Porphyrin-aminoquinoline conjugates as telomerase inhibitors. Org Biomol Chem 1 922 (2003) 921-927
30. Strauss A.W., Nunn A., and Linder K. Nitroimidazoles for imaging hypoxic myocardium. J Nucl Cardiol 2 (1995) 437-445
31. 186/188Re]-labelled porphyrin for targeted radiotherapy. Nucl Med Commun 22 (2001) 1101-1107